SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-126384
Filing Date
2020-04-29
Accepted
2020-04-29 16:50:04
Documents
3
Period of Report
2020-06-18
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d167487ddef14a.htm DEF 14A 298591
2 GRAPHIC g167487g05d64.jpg GRAPHIC 144363
3 GRAPHIC g167487g06s42.jpg GRAPHIC 162680
  Complete submission text file 0001193125-20-126384.txt   722896
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38997 | Film No.: 20831141
SIC: 2834 Pharmaceutical Preparations